Cytokines as biomarkers and therapeutic targets in Emery-Dreifuss muscular dystrophy
• Objective: The purpose of this study is to determine whether cytokines, inflammatory mediators, and in particular IL-6, increased in cells and in the blood of patients with Emery-Dreifuss muscular dystrophy. Also determine if they correlate with the severity of the disease, and if they can be used as biomarkers of disease progression and / or therapeutic targets in patients.
• Project Manager: Dr. G. Lattanzi, CNR-Institute of Molecular Genetics - Bologna Unit
• Status: Completed